Conakry

REUTERS by Aharon Begley                                                                    Aug. 22, 2015
NEW YORK --An experimental Ebola drug from Tekmira Pharmaceuticals Corp cured all three monkeys intentionally infected with the virus, scientists reported on Wednesday, the first such success against the strain of Ebola in West Africa's 2014-2015 outbreak.

Although other experimental treatments appeared to help Ebola patients last year, especially in the United States, those one-time uses cannot prove efficacy against the "Makona" strain, since patients' recovery might be due to other causes. Similarly, drugs, including Mapp Biopharmaceutical's ZMapp, cured monkeys in lab experiments, but in a strain of Ebola different from that responsible for the current outbreak, the worst ever recorded.

"We can't say for certain that an experimental drug that works against one strain will work in another, even if they're almost identical genetically," said Thomas Geisbert of the University of Texas Medical Branch, senior author of the study published in the journal Nature.

QUARTZ  by Grace Dobush                                         March 13, 2015

AUSTIN, Texas—Perhaps the most surprising and important product debuting at SXSW Interactive this year is a personal protective equipment (PPE) prototype for health care workers dealing with Ebola, a tangible result of the U.S. government adapting the culture of innovation and design thinking so key in the startup world.

A team from the U.S. Agency for International Development demonstrated the traditional Ebola suit and the new suit in a preview for Quartz....

THE DALLAS MORNING NEWS                                                                               Nov. 15, 2014

By Sherry Jacobson

The “Ebola cluster” in Dallas County is the subject of the Morbidity and Mortality Weekly Report published Friday by the Centers for Disease Control and Prevention.

...the report offers a detailed timeline of what happened, starting with Thomas Eric Duncan’s arrival in Dallas from Liberia on Sept. 20. His Ebola symptoms were misdiagnosed Sept. 25 at Texas Health Presbyterian Hospital Dallas as sinusitis and he was sent home with antibiotics. He returned to the hospital Sept. 28, underwent 10 days of treatment and died Oct. 8.

Two of Duncan’s caretakers, both registered nurses, were also infected and were treated successfully for the disease. Protocols required public health workers to monitor 177 people who had contact with the three Ebola patients.

A dozen people in that group, however, were tested for Ebola after developing fever or other symptoms compatible with the disease during the monitoring period. None were found to have Ebola. By last Friday, all contacts had cleared 21 days of monitoring and the county’s outbreak was declared over.

ABC NEWS                                                                                                            Nov 7, 2014

by  Sydney Ludkin 

DALLAS The final person in Texas being monitored for Ebola has passed the virus's 21-day incubation period, marking the end of the state's Ebola crisis.

None of the 177 people who had contact with the state's Ebola patients -- Liberian national Thomas Eric Duncan, the first person to be diagnosed with Ebola in the United States, and two of the Dallas nurses who cared for him, Nina Pham and Amber Vinson -- have contracted Ebola, state officials said. The list included health care workers, people who shared the same households as the Ebola patients and other community contacts.

"Hopefully, Americans will be relieved and fear will be eased," said Dr. Richard Besser, ABC News chief health and medical editor. "In Dallas, not even the people who lived with a very sick person with Ebola became ill."

Read complete story

http://abcnews.go.com/Health/person-completes-ebola-monitoring-texas/story?id=26742640